Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantSHOEI UNIVERSAL CORPORATION PTE LTD
Licence HolderSHOEI UNIVERSAL CORPORATION PTE LTD
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INJECTION, POWDER, FOR SOLUTION
INTRAVENOUS, INTRAMUSCULAR
Medical Information
J01DD02
ceftazidime
Manufacturer Information
SHOEI UNIVERSAL CORPORATION PTE LTD
HANMI PHARM CO LTD
Active Ingredients
Ceftazidime pentahydrate with sod. carbonate1.121g/vial eqv Ceftazidime Pentahydrate
1 g/vial